Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 3Recruiting 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 233Head and Neck Neoplasms 150Squamous Cell Carcinoma of Head and Neck 136Stomach Neoplasms 117Lung Neoplasms 109Esophageal Neoplasms 90Uterine Cervical Neoplasms 72Neoplasms 67Urinary Bladder Neoplasms 56Breast Neoplasms 48Ovarian Neoplasms 46Esophageal Squamous Cell Carcinoma 45Pancreatic Neoplasms 44Small Cell Lung Carcinoma 42Neoplasm Metastasis 40Adenocarcinoma Of Esophagus 38Carcinoma, Squamous Cell 33Carcinoma, Ovarian Epithelial 32Mesothelioma, Malignant 30Parkinson Disease 4, Autosomal Dominant Lewy Body 28Lymphoma 28Adenocarcinoma of Lung 25Sarcoma 24Cholangiocarcinoma 24Nasopharyngeal Carcinoma 22Carcinoma 22Unspecified Adult Solid Tumor, Protocol Specific 21Neuroblastoma 21Gallbladder Neoplasms 21Central Nervous System Neoplasms 21

Interventions

Cisplatin 2durvalumab 1atezolizumab 1Radiotherapy 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Locally Advanced Cervical Cancer × Cisplatin × Clear all
NCT03612791 2026-04-03

ATEZOLACC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed
189 enrolled
Gynecologic

Locally Advanced Cervical Cancer

NCT03830866 2024-07-26

CALLA

AstraZeneca

Phase 3 Completed
770 enrolled 12 charts
Gynecologic

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡